A Trial of Cabazitaxel for Advanced Transitional Cell Carcinoma (TCC)
NCT01600339
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
19
Enrollment
OTHER
Sponsor class
Conditions
Urothelial Carcinoma
Interventions
DRUG:
CABAZITAXEL
Sponsor
Rambam Health Care Campus